{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:05:27Z","timestamp":1783483527823,"version":"3.55.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03901-5","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T11:20:39Z","timestamp":1763464839000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Anti-M\u00fcllerian hormone plays a bidirectional role in cancer: a multi-database and multi-method study"],"prefix":"10.1007","volume":"16","author":[{"given":"Yanan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zirui","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzheng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangdong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanyu","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"3901_CR1","doi-asserted-by":"publisher","first-page":"219","DOI":"10.11613\/BM.2011.031","volume":"21","author":"I Zec","year":"2011","unstructured":"Zec I, Tislaric-Medenjak D, Megla ZB, Kucak I. Anti-M\u00fcllerian hormone: a unique biochemical marker of gonadal development and fertility in humans. Biochem Med (Zagreb). 2011;21:219\u201330.","journal-title":"Biochem Med (Zagreb)"},{"key":"3901_CR2","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1055\/s-0038-1676059","volume":"40","author":"GAR Maciel","year":"2018","unstructured":"Maciel GAR, Baracat EC, de S\u00e1 MFS. About the Anti-M\u00fcllerian hormone (AMH) uses in the clinical practice. Rev Bras Ginecol Obstet. 2018;40:661\u20133.","journal-title":"Rev Bras Ginecol Obstet"},{"key":"3901_CR3","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1093\/carcin\/bgs281","volume":"33","author":"PS Tanwar","year":"2012","unstructured":"Tanwar PS, Commandeur AE, Zhang L, Taketo MM, Teixeira JM. The M\u00fcllerian inhibiting substance type 2 receptor suppresses tumorigenesis in testes with sustained \u03b2-catenin signaling. Carcinogenesis. 2012;33:2351\u201361.","journal-title":"Carcinogenesis"},{"key":"3901_CR4","doi-asserted-by":"publisher","first-page":"e2104809118","DOI":"10.1073\/pnas.2104809118","volume":"118","author":"KN Hart","year":"2021","unstructured":"Hart KN, Stocker WA, Nagykery NG, Walton KL, Harrison CA, Donahoe PK, et al. Structure of AMH bound to AMHR2 provides insight into a unique signaling pair in the TGF-\u03b2 family. Proc Natl Acad Sci U S A. 2021;118:e2104809118.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3901_CR5","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2217\/fon.09.172","volume":"6","author":"DT MacLaughlin","year":"2010","unstructured":"MacLaughlin DT, Donahoe PK. M\u00fcllerian inhibiting substance\/anti-M\u00fcllerian hormone: a potential therapeutic agent for human ovarian and other cancers. Future Oncol. 2010;6:391\u2013405.","journal-title":"Future Oncol"},{"key":"3901_CR6","first-page":"305","volume":"10","author":"J-M Barret","year":"2021","unstructured":"Barret J-M, Nicolas A, Jarry A, Dubreuil O, Meseure D, Passat T, et al. The expression of Anti-M\u00fcllerian hormone type II receptor (AMHRII) in Non-Gynecological solid tumors offers potential for broad therapeutic intervention in cancer. Biology (Basel). 2021;10:305.","journal-title":"Biology (Basel)"},{"key":"3901_CR7","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1038\/s41598-021-81819-y","volume":"11","author":"M Chauvin","year":"2021","unstructured":"Chauvin M, Garambois V, Colombo P-E, Chentouf M, Gros L, Brouillet J-P, et al. Anti-M\u00fcllerian hormone (AMH) autocrine signaling promotes survival and proliferation of ovarian cancer cells. Sci Rep. 2021;11:2231.","journal-title":"Sci Rep"},{"key":"3901_CR8","first-page":"2337","volume":"12","author":"H Fei","year":"2022","unstructured":"Fei H, Chen X. Development of a novel five-gene immune-related risk model for the prognosis evaluation of prostate adenocarcinoma patients. Am J Cancer Res. 2022;12:2337\u201349.","journal-title":"Am J Cancer Res"},{"key":"3901_CR9","doi-asserted-by":"publisher","first-page":"112730","DOI":"10.1016\/j.celrep.2023.112730","volume":"42","author":"M Chauvin","year":"2023","unstructured":"Chauvin M, Meinsohn M-C, Dasari S, May P, Iyer S, Nguyen NMP, et al. Cancer-associated mesothelial cells are regulated by the anti-M\u00fcllerian hormone axis. Cell Rep. 2023;42:112730.","journal-title":"Cell Rep"},{"key":"3901_CR10","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.3390\/cancers13081845","volume":"13","author":"M Prat","year":"2021","unstructured":"Prat M, Salon M, Allain T, Dubreuil O, No\u00ebl G, Preisser L, et al. Murlentamab, a low fucosylated Anti-M\u00fcllerian hormone type II receptor (AMHRII) Antibody, exhibits Anti-Tumor activity through Tumor-Associated macrophage reprogrammation and T cell activation. Cancers (Basel). 2021;13:1845.","journal-title":"Cancers (Basel)"},{"key":"3901_CR11","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/MED.0000000000000447","volume":"25","author":"QHY Wong","year":"2018","unstructured":"Wong QHY, Anderson RA. The role of antimullerian hormone in assessing ovarian damage from chemotherapy, radiotherapy and surgery. Curr Opin Endocrinol Diabetes Obes. 2018;25:391\u20138.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"3901_CR12","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/jrsm.1429","volume":"11","author":"J Shi","year":"2020","unstructured":"Shi J, Luo D, Weng H, Zeng X-T, Lin L, Chu H, et al. Optimally estimating the sample standard deviation from the five-number summary. Res Synth Methods. 2020;11:641\u201354.","journal-title":"Res Synth Methods"},{"key":"3901_CR13","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603\u20135.","journal-title":"Eur J Epidemiol"},{"key":"3901_CR14","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1093\/humrep\/deac028","volume":"37","author":"RMG Verdiesen","year":"2022","unstructured":"Verdiesen RMG, van der Schouw YT, van Gils CH, Verschuren WMM, Broekmans FJM, Borges MC, et al. Genome-wide association study meta-analysis identifies three novel loci for Circulating anti-M\u00fcllerian hormone levels in women. Hum Reprod. 2022;37:1069\u201382.","journal-title":"Hum Reprod"},{"key":"3901_CR15","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki MI, Karjalainen J, Palta P, Sipil\u00e4 TP, Kristiansson K, Donner KM, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613:508\u201318.","journal-title":"Nature"},{"key":"3901_CR16","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/ng.3826","volume":"49","author":"CM Phelan","year":"2017","unstructured":"Phelan CM, Kuchenbaecker KB, Tyrer JP, Kar SP, Lawrenson K, Winham SJ, et al. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer. Nat Genet. 2017;49:680\u201391.","journal-title":"Nat Genet"},{"key":"3901_CR17","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1038\/s41588-023-01534-4","volume":"55","author":"A Wang","year":"2023","unstructured":"Wang A, Shen J, Rodriguez AA, Saunders EJ, Chen F, Janivara R, et al. Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants. Nat Genet. 2023;55:2065\u201374.","journal-title":"Nat Genet"},{"key":"3901_CR18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41588-022-01222-9","volume":"55","author":"C Fernandez-Rozadilla","year":"2023","unstructured":"Fernandez-Rozadilla C, Timofeeva M, Chen Z, Law P, Thomas M, Schmit S, et al. Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and East Asian ancestries. Nat Genet. 2023;55:89\u201399.","journal-title":"Nat Genet"},{"key":"3901_CR19","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1038\/s41588-021-00954-4","volume":"53","author":"L Jiang","year":"2021","unstructured":"Jiang L, Zheng Z, Fang H, Yang J. A generalized linear mixed model association tool for biobank-scale data. Nat Genet. 2021;53:1616\u201321.","journal-title":"Nat Genet"},{"key":"3901_CR20","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1158\/0008-5472.CAN-20-0985","volume":"80","author":"S-H Lin","year":"2020","unstructured":"Lin S-H, Brown DW, Machiela MJ. LDtrait: an online tool for identifying published phenotype associations in linkage disequilibrium. Cancer Res. 2020;80:3443\u20136.","journal-title":"Cancer Res"},{"key":"3901_CR21","doi-asserted-by":"publisher","first-page":"e34408","DOI":"10.7554\/eLife.34408","volume":"7","author":"G Hemani","year":"2018","unstructured":"Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7:e34408.","journal-title":"Elife"},{"key":"3901_CR22","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s40471-017-0128-6","volume":"4","author":"J Zheng","year":"2017","unstructured":"Zheng J, Baird D, Borges M-C, Bowden J, Hemani G, Haycock P, et al. Recent developments in Mendelian randomization studies. Curr Epidemiol Rep. 2017;4:330\u201345.","journal-title":"Curr Epidemiol Rep"},{"key":"3901_CR23","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","volume":"326","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova VW, Richmond RC, Woolf BAR, Yarmolinsky J, Davies NM, Swanson SA, et al. Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement. JAMA. 2021;326:1614.","journal-title":"JAMA"},{"key":"3901_CR24","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/s42003-024-06891-2","volume":"7","author":"S Li","year":"2024","unstructured":"Li S, Peng Y, Chen M, Zhao Y, Xiong Y, Li J, et al. Facilitating integrative and personalized oncology omics analysis with UCSCXenaShiny. Commun Biol. 2024;7:1200.","journal-title":"Commun Biol"},{"key":"3901_CR25","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48:W509\u201314.","journal-title":"Nucleic Acids Res"},{"key":"3901_CR26","doi-asserted-by":"publisher","first-page":"bbac558","DOI":"10.1093\/bib\/bbac558","volume":"24","author":"C-J Liu","year":"2023","unstructured":"Liu C-J, Hu F-F, Xie G-Y, Miao Y-R, Li X-W, Zeng Y, et al. GSCA: an integrated platform for gene set cancer analysis at genomic, Pharmacogenomic and Immunogenomic levels. Brief Bioinform. 2023;24:bbac558.","journal-title":"Brief Bioinform"},{"key":"3901_CR27","doi-asserted-by":"publisher","first-page":"D1425","DOI":"10.1093\/nar\/gkac959","volume":"51","author":"Y Han","year":"2023","unstructured":"Han Y, Wang Y, Dong X, Sun D, Liu Z, Yue J, et al. TISCH2: expanded datasets and new tools for single-cell transcriptome analyses of the tumor microenvironment. Nucleic Acids Res. 2023;51:D1425\u201331.","journal-title":"Nucleic Acids Res"},{"key":"3901_CR28","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44:W90\u201397.","journal-title":"Nucleic Acids Res"},{"key":"3901_CR29","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1002\/ijc.31249","volume":"142","author":"W Ge","year":"2018","unstructured":"Ge W, Clendenen TV, Afanasyeva Y, Koenig KL, Agnoli C, Brinton LA, et al. Circulating anti-M\u00fcllerian hormone and breast cancer risk: A study in ten prospective cohorts. Int J Cancer. 2018;142:2215\u201326.","journal-title":"Int J Cancer"},{"key":"3901_CR30","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1038\/sj.bjc.6603814","volume":"96","author":"K Lutchman Singh","year":"2007","unstructured":"Lutchman Singh K, Muttukrishna S, Stein RC, McGarrigle HH, Patel A, Parikh B, et al. Predictors of ovarian reserve in young women with breast cancer. Br J Cancer. 2007;96:1808\u201316.","journal-title":"Br J Cancer"},{"key":"3901_CR31","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s10549-012-2361-5","volume":"137","author":"HI Su","year":"2013","unstructured":"Su HI, Flatt SW, Natarajan L, DeMichele A, Steiner AZ. Impact of breast cancer on anti-mullerian hormone levels in young women. Breast Cancer Res Treat. 2013;137:571\u20137.","journal-title":"Breast Cancer Res Treat"},{"key":"3901_CR32","first-page":"181","volume":"19","author":"A Jalaeefar","year":"2021","unstructured":"Jalaeefar A, Moini A, Eslami B, Alipour S, Shirkhoda M, Aryan A, et al. Abnormal anti-M\u00fcllerian hormone level May be a trigger for breast cancer in young women: A case-control study. Int J Reprod Biomed. 2021;19:181\u201390.","journal-title":"Int J Reprod Biomed"},{"key":"3901_CR33","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/cncr.25037","volume":"116","author":"B Yu","year":"2010","unstructured":"Yu B, Douglas N, Ferin MJ, Nakhuda GS, Crew K, Lobo RA, et al. Changes in markers of ovarian reserve and endocrine function in young women with breast cancer undergoing adjuvant chemotherapy. Cancer. 2010;116:2099\u2013105.","journal-title":"Cancer"},{"key":"3901_CR34","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s10815-019-01658-9","volume":"37","author":"E Porcu","year":"2019","unstructured":"Porcu E, Cillo GM, Cipriani L, Sacilotto F, Notarangelo L, Damiano G, et al. Impact of BRCA1 and BRCA2 mutations on ovarian reserve and fertility preservation outcomes in young women with breast cancer. J Assist Reprod Genet. 2019;37:709\u201315.","journal-title":"J Assist Reprod Genet"},{"key":"3901_CR35","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.fertnstert.2018.10.014","volume":"111","author":"V Gunnala","year":"2019","unstructured":"Gunnala V, Fields J, Irani M, D\u2019Angelo D, Xu K, Schattman G, et al. BRCA carriers have similar reproductive potential at baseline to noncarriers: comparisons in cancer and cancer-free cohorts undergoing fertility preservation. Fertil Steril. 2019;111:363\u201371.","journal-title":"Fertil Steril"},{"key":"3901_CR36","first-page":"BC19","volume":"10","author":"J Bala","year":"2016","unstructured":"Bala J, Seth S, Dhankhar R, Ghalaut VS. Chemotherapy: impact on Anti-M\u00fcllerian hormone levels in breast carcinoma. J Clin Diagn Res. 2016;10:BC19\u201321.","journal-title":"J Clin Diagn Res"},{"key":"3901_CR37","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1158\/1055-9965.EPI-19-0675","volume":"29","author":"SR Irvin","year":"2020","unstructured":"Irvin SR, Weiderpass E, Stanczyk FZ, Brinton LA, Trabert B, Langseth H, et al. Association of Anti-Mullerian Hormone, Follicle-Stimulating Hormone, and inhibin B with risk of ovarian cancer in the Janus serum bank. Cancer Epidemiol Biomarkers Prev. 2020;29:636\u201342.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"3901_CR38","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/ijc.31058","volume":"142","author":"S Jung","year":"2018","unstructured":"Jung S, Allen N, Arslan AA, Baglietto L, Barricarte A, Brinton LA, et al. Anti-M\u00fcllerian hormone and risk of ovarian cancer in nine cohorts. Int J Cancer. 2018;142:262\u201370.","journal-title":"Int J Cancer"},{"key":"3901_CR39","first-page":"583","volume":"25","author":"H Schock","year":"2014","unstructured":"Schock H, Lundin E, V\u00e4\u00e4r\u00e4sm\u00e4ki M, Grankvist K, Fry A, Dorgan JF, et al. Anti-Mullerian hormone and risk of invasive serous ovarian cancer. Cancer Causes Control. 2014;25:583\u20139.","journal-title":"Cancer Causes Control"},{"key":"3901_CR40","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1038\/bjc.2017.299","volume":"117","author":"RT Fortner","year":"2017","unstructured":"Fortner RT, Schock H, Jung S, Allen NE, Arslan AA, Brinton LA, et al. Anti-Mullerian hormone and endometrial cancer: a multi-cohort study. Br J Cancer. 2017;117:1412\u20138.","journal-title":"Br J Cancer"},{"key":"3901_CR41","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.fertnstert.2012.04.021","volume":"98","author":"B Lawrenz","year":"2012","unstructured":"Lawrenz B, Fehm T, von Wolff M, Soekler M, Huebner S, Henes J, et al. Reduced pretreatment ovarian reserve in premenopausal female patients with hodgkin lymphoma or non-Hodgkin-lymphoma\u2013evaluation by using antim\u00fcllerian hormone and retrieved oocytes. Fertil Steril. 2012;98:141\u20134.","journal-title":"Fertil Steril"},{"key":"3901_CR42","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s10815-016-0689-1","volume":"33","author":"J Lekovich","year":"2016","unstructured":"Lekovich J, Lobel ALS, Stewart JD, Pereira N, Kligman I, Rosenwaks Z. Female patients with lymphoma demonstrate diminished ovarian reserve even before initiation of chemotherapy when compared with healthy controls and patients with other malignancies. J Assist Reprod Genet. 2016;33:657\u201362.","journal-title":"J Assist Reprod Genet"},{"key":"3901_CR43","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1093\/humrep\/dem392","volume":"23","author":"S Lie Fong","year":"2008","unstructured":"Lie Fong S, Lugtenburg PJ, Schipper I, Themmen APN, de Jong FH, Sonneveld P, et al. Anti-m\u00fcllerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematological malignancies. Hum Reprod. 2008;23:674\u20138.","journal-title":"Hum Reprod"},{"key":"3901_CR44","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1093\/humrep\/det442","volume":"29","author":"W van Dorp","year":"2014","unstructured":"van Dorp W, van den Heuvel-Eibrink MM, de Vries ACH, Pluijm SMF, Visser JA, Pieters R, et al. Decreased serum anti-M\u00fcllerian hormone levels in girls with newly diagnosed cancer. Hum Reprod. 2014;29:337\u201342.","journal-title":"Hum Reprod"},{"key":"3901_CR45","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1080\/09513590.2016.1188373","volume":"32","author":"R Paradisi","year":"2016","unstructured":"Paradisi R, Macciocca M, Vicenti R, Rossi S, Morselli-Labate AM, Mastroroberto M, et al. New insights in the selection and management of cancer patients applicants for ovarian tissue cryopreservation. Gynecol Endocrinol. 2016;32:881\u20135.","journal-title":"Gynecol Endocrinol"},{"key":"3901_CR46","doi-asserted-by":"publisher","first-page":"159","DOI":"10.12688\/f1000research.15728.1","volume":"8","author":"AK Harzif","year":"2019","unstructured":"Harzif AK, Wiweko B, Addina P, Iswaranti K, Silvia M, Mariana A, et al. Anti-Mullerian hormone levels in female cancer patients of reproductive age in indonesia: A cross-sectional study. F1000Res. 2019;8:159.","journal-title":"F1000Res"},{"key":"3901_CR47","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.rbmo.2018.01.016","volume":"36","author":"C Decanter","year":"2018","unstructured":"Decanter C, Robin G, Mailliez A, Sigala J, Morschhauser F, Ramdane N, et al. Prospective assessment of follicular growth and the oocyte cohort after ovarian stimulation for fertility preservation in 90 cancer patients versus 180 matched controls. Reprod Biomed Online. 2018;36:543\u201351.","journal-title":"Reprod Biomed Online"},{"key":"3901_CR48","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ijgo.2015.10.013","volume":"133","author":"M Naasan","year":"2016","unstructured":"Naasan M, Harrity C, Rajab H, Ranisavljevic N, Khalid S, Mocanu E. Patients with cancer at the margins of reproductive age had reduced levels of anti-M\u00fcllerian hormone compared with patients experiencing infertility. Int J Gynecol Obstet. 2016;133:226\u20139.","journal-title":"Int J Gynecol Obstet"},{"key":"3901_CR49","doi-asserted-by":"publisher","first-page":"1902880","DOI":"10.1002\/advs.201902880","volume":"7","author":"Y-R Miao","year":"2020","unstructured":"Miao Y-R, Zhang Q, Lei Q, Luo M, Xie G-Y, Wang H, et al. ImmuCellAI: A unique method for comprehensive T-Cell subsets abundance prediction and its application in cancer immunotherapy. Adv Sci (Weinh). 2020;7:1902880.","journal-title":"Adv Sci (Weinh)"},{"key":"3901_CR50","doi-asserted-by":"publisher","first-page":"hoad024","DOI":"10.1093\/hropen\/hoad024","volume":"2023","author":"M Wu","year":"2023","unstructured":"Wu M, Zhu Q, Huang Y, Tang W, Dai J, Guo Y, et al. Ovarian reserve in reproductive-aged patients with cancer before gonadotoxic treatment: a systematic review and meta-analysis. Hum Reprod Open. 2023;2023:hoad024.","journal-title":"Hum Reprod Open"},{"key":"3901_CR51","doi-asserted-by":"publisher","first-page":"103978","DOI":"10.1016\/j.rbmo.2024.103978","volume":"49","author":"T Katzir","year":"2024","unstructured":"Katzir T, Shrem G, Meirow D, Berkowitz E, Elizur S, Cohen S, et al. Fertility preservation parameters in patients with haematologic malignancy: a systematic review and meta-analysis. Reprod Biomed Online. 2024;49:103978.","journal-title":"Reprod Biomed Online"},{"key":"3901_CR52","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ygyno.2009.02.023","volume":"114","author":"HL Chang","year":"2009","unstructured":"Chang HL, Pahlavan N, Halpern EF, MacLaughlin DT. Serum M\u00fcllerian inhibiting Substance\/Anti-M\u00fcllerian hormone levels in patients with adult granulosa cell tumors directly correlate with aggregate tumor mass as determined by pathology or radiology. Gynecol Oncol. 2009;114:57\u201360.","journal-title":"Gynecol Oncol"},{"key":"3901_CR53","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1073\/pnas.221599298","volume":"99","author":"DL Segev","year":"2002","unstructured":"Segev DL, Hoshiya Y, Hoshiya M, Tran TT, Carey JL, Stephen AE, et al. Mullerian-inhibiting substance regulates NF-kappa B signaling in the prostate in vitro and in vivo. Proc Natl Acad Sci U S A. 2002;99:239\u201344.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3901_CR54","doi-asserted-by":"publisher","first-page":"17426","DOI":"10.1073\/pnas.0607959103","volume":"103","author":"R Pieretti-Vanmarcke","year":"2006","unstructured":"Pieretti-Vanmarcke R, Donahoe PK, Pearsall LA, Dinulescu DM, Connolly DC, Halpern EF, et al. Mullerian inhibiting substance enhances subclinical doses of chemotherapeutic agents to inhibit human and mouse ovarian cancer. Proc Natl Acad Sci USA. 2006;103:17426\u201331.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3901_CR55","first-page":"2101","volume":"51","author":"T Chin","year":"1991","unstructured":"Chin T, Parry RL, Donahoe PK. Human M\u00fcllerian inhibiting substance inhibits tumor growth in vitro and in Vivo1. Cancer Res. 1991;51:2101\u20136.","journal-title":"Cancer Res"},{"key":"3901_CR56","doi-asserted-by":"publisher","first-page":"149461","DOI":"10.1016\/j.gene.2025.149461","volume":"955","author":"MJ Saadh","year":"2025","unstructured":"Saadh MJ, Omar TM, Ballal S, Mahdi MS, Chahar M, Verma R, et al. Notch signaling and cancer: insights into chemoresistance, immune evasion, and immunotherapy. Gene. 2025;955:149461.","journal-title":"Gene"},{"key":"3901_CR57","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.celrep.2016.06.043","volume":"16","author":"TN Beck","year":"2016","unstructured":"Beck TN, Korobeynikov VA, Kudinov AE, Georgopoulos R, Solanki NR, Andrews-Hoke M, et al. Anti-M\u00fcllerian hormone signaling regulates epithelial plasticity and chemoresistance in lung cancer. Cell Rep. 2016;16:657\u201371.","journal-title":"Cell Rep"},{"key":"3901_CR58","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.15309","author":"Y Koinuma","year":"2024","unstructured":"Koinuma Y, Mitsuishi Y, Winardi W, Hidayat M, Wirawan A, Hayakawa D, et al. Anti-M\u00fcllerian hormone type II receptor protein expression in non-small cell lung cancer and the effect of AMH\/AMHR2 signaling on cancer cell proliferation. Thorac Cancer. 2024. https:\/\/doi.org\/10.1111\/1759-7714.15309.","journal-title":"Thorac Cancer"},{"key":"3901_CR59","doi-asserted-by":"publisher","first-page":"1468364","DOI":"10.3389\/fendo.2024.1468364","volume":"15","author":"M Gowkielewicz","year":"2024","unstructured":"Gowkielewicz M, Lipka A, Zdanowski W, Wa\u015bniewski T, Majewska M, Carlberg C. Anti-M\u00fcllerian hormone: biology and role in endocrinology and cancers. Front Endocrinol. 2024;15:1468364.","journal-title":"Front Endocrinol"},{"key":"3901_CR60","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.2967\/jnumed.118.208611","volume":"59","author":"E Deshayes","year":"2018","unstructured":"Deshayes E, Ladjohounlou R, Le Fur P, Pichard A, Lozza C, Boudousq V, et al. Radiolabeled antibodies against M\u00fcllerian-Inhibiting substance Receptor, type II: new tools for a theranostic approach in ovarian cancer. J Nucl Med. 2018;59:1234\u201342.","journal-title":"J Nucl Med"},{"key":"3901_CR61","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1093\/humrep\/deab189","volume":"36","author":"C Decanter","year":"2021","unstructured":"Decanter C, Delepine J, Behal H, Manier S, Bruno B, Barbatti M, et al. Longitudinal study of AMH variations in 122 adolescents and young adults (AYA) and non-AYA lymphoma patients to evaluate the chemo-induced ovarian toxicity to further personalise fertility preservation counselling. Hum Reprod. 2021;36:2743\u201352.","journal-title":"Hum Reprod"},{"key":"3901_CR62","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1093\/humupd\/dmad002","volume":"29","author":"KCE Drechsel","year":"2023","unstructured":"Drechsel KCE, Pilon MCF, Stoutjesdijk F, Meivis S, Schoonmade LJ, Wallace WHB, et al. Reproductive ability in survivors of childhood, adolescent, and young adult hodgkin lymphoma: a review. Hum Reprod Update. 2023;29:486\u2013517.","journal-title":"Hum Reprod Update"},{"key":"3901_CR63","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1089\/thy.2020.0356","volume":"31","author":"MW Piek","year":"2021","unstructured":"Piek MW, Postma EL, van Leeuwaarde R, de Boer JP, Bos AME, Lok C, et al. The effect of radioactive iodine therapy on ovarian function and fertility in female thyroid cancer patients: A systematic review and Meta-Analysis. Thyroid. 2021;31:658\u201368.","journal-title":"Thyroid"},{"key":"3901_CR64","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.maturitas.2021.04.002","volume":"148","author":"P Anagnostis","year":"2021","unstructured":"Anagnostis P, Florou P, Bosdou JK, Grimbizis GF, Iakovou I, Kolibianakis EM, et al. Decline in anti-M\u00fcllerian hormone concentrations following radioactive iodine treatment in women with differentiated thyroid cancer: A systematic review and meta-analysis. Maturitas. 2021;148:40\u20135.","journal-title":"Maturitas"},{"key":"3901_CR65","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s10815-015-0490-6","volume":"32","author":"W Gao","year":"2015","unstructured":"Gao W, Liang J-X, Yan Q. Exposure to radiation therapy is associated with female reproductive health among childhood cancer survivors: a meta-analysis study. J Assist Reprod Genet. 2015;32:1179\u201386.","journal-title":"J Assist Reprod Genet"},{"key":"3901_CR66","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/humupd\/dmac004","volume":"28","author":"RA Anderson","year":"2022","unstructured":"Anderson RA, Cameron D, Clatot F, Demeestere I, Lambertini M, Nelson SM, et al. Anti-M\u00fcllerian hormone as a marker of ovarian reserve and premature ovarian insufficiency in children and women with cancer: a systematic review. Hum Reprod Update. 2022;28:417\u201334.","journal-title":"Hum Reprod Update"},{"key":"3901_CR67","doi-asserted-by":"publisher","first-page":"1135467","DOI":"10.3389\/fendo.2023.1135467","volume":"14","author":"J Lopez Dacal","year":"2023","unstructured":"Lopez Dacal J, Prada S, Correa Brito L, Ropelato MG, Ballerini MG, Rodriguez ME, et al. Testicular dysfunction at diagnosis in children and teenagers with Haematopoietic malignancies improves after initial chemotherapy. Front Endocrinol (Lausanne). 2023;14:1135467.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3901_CR68","doi-asserted-by":"crossref","unstructured":"Nguyen NMP, Chang EM, Chauvin M, Sicher N, Kashiwagi A, Nagykery N, et al. AMH protects the ovary from doxorubicin by regulating cell fate and the response to DNA damage. BioRxiv. 2024.05.23.595356. 2024.","DOI":"10.1101\/2024.05.23.595356"},{"key":"3901_CR69","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41392-024-01823-2","volume":"9","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Tao L, Qiu J, Xu J, Yang X, Zhang Y, et al. Tumor biomarkers for diagnosis, prognosis and targeted therapy. Sig Transduct Target Ther. 2024;9:132.","journal-title":"Sig Transduct Target Ther"},{"key":"3901_CR70","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ejogrb.2020.08.011","volume":"253","author":"S Chen","year":"2020","unstructured":"Chen S, Yang B, Fan J. Diagnostic value of Anti-Mullerian hormone in ovarian granulosa cell tumor: A meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2020;253:266\u201372.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"3901_CR71","doi-asserted-by":"publisher","first-page":"691432","DOI":"10.3389\/fendo.2021.691432","volume":"12","author":"HWR Li","year":"2021","unstructured":"Li HWR, Robertson DM, Burns C, Ledger WL. Challenges in measuring AMH in the clinical setting. Front Endocrinol (Lausanne). 2021;12:691432.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3901_CR72","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1210\/clinem\/dgaa513","volume":"105","author":"LME Moolhuijsen","year":"2020","unstructured":"Moolhuijsen LME, Visser JA. Anti-M\u00fcllerian hormone and ovarian reserve: update on assessing ovarian function. J Clin Endocrinol Metab. 2020;105:3361\u201373.","journal-title":"J Clin Endocrinol Metab"},{"key":"3901_CR73","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s42000-023-00520-z","volume":"23","author":"S Kontogiannis","year":"2024","unstructured":"Kontogiannis S, Markantes G, Stamou M, Tsagkarakis M, Mamali I, Giannitsas K, et al. Anti-M\u00fcllerian hormone: a novel biomarker for aggressive prostate cancer? Emerging evidence from a prospective study of radical prostatectomies. Horm (Athens). 2024;23:297\u2013304.","journal-title":"Horm (Athens)"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03901-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03901-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03901-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:04:33Z","timestamp":1763510673000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03901-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3901"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03901-5","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"23 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2124"}}